Astrocyte dysfunction causes cognitive decline

Date:
April 20, 2023
Source:
Weill Cornell Medicine
Summary:
People with dementia have protein build-up in astrocytes that may
trigger abnormal antiviral activity and memory loss, according to
a preclinical study.


Facebook Twitter Pinterest LinkedIN Email
FULL STORY ========================================================================== People with dementia have protein build-up in astrocytes that may trigger abnormal antiviral activity and memory loss, according to a preclinical
study by a team of Weill Cornell Medicine investigators.


========================================================================== Dysfunction in cells called neurons, which transmit messages throughout
the brain, has long been the prime suspect in dementia-related cognitive deficits.

But a new study, published in Science Advances on April 19, suggests that abnormal immune activity in non-neuronal brain cells called astrocytes is sufficient to cause cognitive deficits in dementia. The discovery could
lead to new treatments that reduce excess immune activity in astrocytes
and their detrimental effects on other brain cells and cognition.

"Astrocyte dysfunction alone can drive memory loss, even when neurons
and other cells are otherwise healthy," said co-senior author Dr. Anna
Orr, the Nan and Stephen Swid Assistant Professor of Frontotemporal
Dementia Research in the Feil Family Brain and Mind Research Institute
and a member of the Helen and Robert Appel Alzheimer's Disease Research Institute at Weill Cornell Medicine.

"We found, in mice, that astrocytes can cause cognitive decline through
their antiviral activities, which can make neurons hyperactive." While
neurons have been intensively studied in dementia and other diseases,
much less research has focused on astrocytes, which many scientists
viewed as playing only supporting roles to neurons in brain health.

"We are very interested in the roles of astrocytes in cognitive
and behavioral disorders," she said. "These cells are prevalent in
the brain and perform various key functions, but their involvement
in neurocognitive disorders like dementia are poorly understood."
When the investigators, including first author Dr. Avital Licht-Murava,
a former postdoctoral associate in the Orr lab, examined tissue samples
from deceased individuals who were diagnosed with either Alzheimer's
disease or frontotemporal dementia, they found an accumulation of a
protein called TDP-43 in astrocytes within the hippocampus, a brain
region crucial for memory. To understand the effects of this protein
build-up, the team conducted a series of experiments in mouse models and
brain cells grown in the laboratory. Other senior investigators that contributed to the study include Dr. Robert Schwartz at Weill Cornell
Medicine and Dr. Robert Froemke at New York University.

In mice, the build-up of TDP-43 in astrocytes was sufficient to cause progressive memory loss but not other behavioral changes. "Astrocytes in
the hippocampus seem to be more vulnerable to this pathology." she said.

To understand the causes of memory loss at the molecular level, co-senior author Dr. Adam Orr, an assistant professor of research in neuroscience
in the Feil Family Brain and Mind Research Institute and a member
of the Appel Alzheimer's Disease Research Institute at Weill Cornell
Medicine, analyzed gene expression and found high levels of antiviral
gene activities, even though no virus was present in the brain. Astrocytes produced excessive amounts of immune messengers called chemokines, which
can activate CXCR3 chemokine receptors typically found on infiltrating
immune cells. To their surprise, the team discovered that CXCR3 receptor
levels were elevated in hippocampal neurons, and that excessive CXCR3
receptor activity made neurons "hyperactive," Dr. Anna Orr said.

"Blocking CXCR3 reduced neuronal firing in individual neurons and
eliminating CXCR3 in mice by genetic engineering alleviated cognitive
deficits caused by astrocytic TDP-43 build-up," Dr. Adam Orr said. These experiments demonstrate that impaired astrocytes can have a detrimental
role in dementia, he said.

Both investigators were excited by the potential clinical implications
of their findings.

"For effective therapeutics, we need to consider astrocytes along with neurons," Dr. Anna Orr said.

Drugs that target the identified immune pathways might help improve
cognitive function in people with dementia. She noted that scientists are already testing CXCR3 blockers to treat arthritis and other inflammatory conditions in clinical trials. These drugs could be tested and potentially repurposed for dementia.

This study may also provide insights into how antiviral immune responses
can cause cognitive dysfunction. Previous research has linked viral
infections to Alzheimer's disease and to long-term neurocognitive
effects such as memory loss and brain fog. Abnormal immune activity
in astrocytes might contribute to these cognitive effects as well as
increase individuals' susceptibility to viral infections, which could
further worsen brain health and promote some cases of dementia.

The team is currently studying how TDP-43 alters antiviral activities
in astrocytes and whether these changes increase brain susceptibility
to viral pathogens.

"Astrocytes can promote resilience or vulnerability to brain disease,"
Dr. Anna Orr said. "Understanding how they enable cognitive function or
cause cognitive decline will be critical to understanding brain health
and developing effective therapies."
* RELATED_TOPICS
o Mind_&_Brain
# Dementia # Intelligence # Disorders_and_Syndromes #
Alzheimer's # Neuroscience # Brain_Injury # Psychology #
Brain-Computer_Interfaces
* RELATED_TERMS
o Seizure o Multi-infarct_dementia o Dementia_with_Lewy_bodies
o Alzheimer's_disease o Bruxism o Dementia o Limbic_system
o Epilepsy

========================================================================== Story Source: Materials provided by Weill_Cornell_Medicine. Note:
Content may be edited for style and length.


========================================================================== Journal Reference:
1. Avital Licht-Murava, Samantha M. Meadows, Fernando Palaguachi,
Soomin C.

Song, Stephanie Jackvony, Yaron Bram, Constance Zhou, Robert
E. Schwartz, Robert C. Froemke, Adam L. Orr, Anna G. Orr. Astrocytic
TDP-43 dysregulation impairs memory by modulating antiviral
pathways and interferon-inducible chemokines. Science Advances,
2023; 9 (16) DOI: 10.1126/sciadv.ade1282 ==========================================================================

Link to news story: https://www.sciencedaily.com/releases/2023/04/230420135302.htm

--- up 1 year, 7 weeks, 3 days, 10 hours, 50 minutes
* Origin: -=> Castle Rock BBS <=- Now Husky HPT Powered! (1:317/3)